Amenorrhea as a Side Effect of Low Dose Aripiprazole: An Adolescent Case
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Amenorrhea, oligomenorrhea, galactorrhoea, gynecomastia, infertility, and sexual dysfunction may arise as a consequence of hyperprolactinemia. Hyperprolactinemia is one of major side effects of treatment with antipsychotics, but aripiprazole is known as a dopamine stabilizer antipsychotic which can be used to improve hyperprolactinemia. In this report, it was described that an adolescent patient experienced amenorrhea after adding very low dose aripiprazole to ongoing fluoxetine treatment regime for major depressive disorder. Additionally, this case showed that the patient recovered from the amenorrhea with replacement of aripiprazole with quetiapine.
Abstract
Amenorrhea, oligomenorrhea, galactorrhoea, gynecomastia, infertility, and sexual dysfunction may arise as a consequence of hyperprolactinemia. Hyperprolactinemia is one of major side effects of treatment with antipsychotics, but aripiprazole is known as a dopamine stabilizer antipsychotic which can be used to improve hyperprolactinemia. In this report, it was described that an adolescent patient experienced amenorrhea after adding very low dose aripiprazole to ongoing fluoxetine treatment regime for major depressive disorder. Additionally, this case showed that the patient recovered from the amenorrhea with replacement of aripiprazole with quetiapine.
참고문헌 (14)
- Haddad PM, "Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management", Drugs, 64, pp.2291~2314 (2004)[DOI]
- Meng M, "Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials", Shanghai Arch Psychiatry, 27, pp.4~17 (2015)
- Yoon HW, "Comparing the effectiveness and safety of the addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia: a multicenter, open-label, prospective study", Clin Neuropharmacol, 39, pp.288~294 (2016)[DOI]
- Curran RL, "Aripiprazole for the treatment of antipsychotic-induced hyperprolactinemia in an adolescent boy", J Child Adolesc Psychopharmacol, 26, pp.490~491 (2016)[DOI]
- Yasui-Furukori N, "Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia", J Clin Psychopharmacol, 30, pp.596~599 (2010)[DOI]
- Mendhekar DN, "Galactorrhea with aripiprazole", Can J Psychiatry, 50, pp.243~ (2005)
- Joseph SP, "Aripiprazole-induced hyperprolactinemia in a young female with delusional disorder", Indian J Psychol Med, 38, pp.260~262 (2016)[DOI]
- Saraf G, "Hyperprolactinemia with aripiprazole: understanding the paradox", Am J Ther, 21, pp.80~81 (2014)[DOI]
- Kenar ANI, "Hyperprolactinemia with aripiprazole: a case report and review of the literature", Klinik Psikofarmakol Bulteni, 24, pp.257~260 (2014)[DOI]
- Ruffatti A, "Galactorrhea with aripiprazole", Psychother Psychosom, 74, pp.391~392 (2005)[DOI]
- "Drug interactions: cytochrome P450 drug interaction table" (2007)[URL]
- Prior TI, "Interactions between the cytochrome P450 system and the second-generation antipsychotics", J Psychiatry Neurosci, 28, pp.99~112 (2003)
- Pae CU, "Very low dose quetiapine-induced galactorrhea in combination with venlafaxine", Hum Psychopharmacol, 19, pp.433~434 (2004)[DOI]
- Seshadri Sekhar Chatterjee, "Emerging Hyperprolactinemic Galactorrhea in Obsessive Compulsive Disorder with a Stable Dose of Fluoxetine", Clinical Psychopharmacology and Neuroscience, 13(3), pp.316~318 (2015), 대한정신약물학회